期刊文献+

曲古抑菌素A和紫杉醇对子宫内膜癌Ark2细胞凋亡和线粒体膜电位的影响 被引量:7

Effects of Trichostatin A and Paclitaxel on Apoptosis and Mitochondrial Membrane Potential of Human Endometrial Carcinoma Ark2 Cells
下载PDF
导出
摘要 背景与目的:晚期子宫内膜癌患者应用现有的抗癌药物治疗预后较差,5年生存率仅为25%,为降低这类患者死亡率,需研发新的抗癌药物。组蛋白去乙酰基酶抑制剂曲古抑菌素A(Trichostatin,TSA)有望应用于临床各种恶性肿瘤的治疗,与传统的抗肿瘤药物联用可以提高肿瘤患者的生存率。本实验探讨TSA和紫杉醇(paclitaxel,PTX)对人子宫内膜癌Ark2细胞凋亡的影响及其机制。方法:Ark2细胞培养于RPMI-1640培养液中,应用TSA、PTX单独或者联合干预,Annexin V法结合Hoechst33258染色法检测Ark2细胞凋亡;Western blot检测其凋亡信号通路中Caspase-9活化及多聚ADP核糖聚合酶(Poly ADP-ribose polymerase,PARP)裂解情况,以及微管乙酰化的表达及微管稳定性。MitoTracker red法检测其线粒体膜电位。结果:流式细胞仪检测显示,1.5nmol/L PTX联合25nmol/L TSA处理Ark2细胞3d后,可见45.2%的细胞凋亡,明显高于单用1.5nmol/L PTX或25nmol/L TSA组的细胞凋亡率(分别为14.1%、11.2%)。Hoechst33258染色法检测结果与流式细胞仪检测结果一致。TSA和PTX联用组PARP、Caspase-9裂解较单用PTX或TSA明显增加(P<0.05)。Western blot和免疫荧光分析证明PTX和TSA可诱导微管蛋白乙酰化,联合用药后微管蛋白乙酰化明显增加,微管稳定性增强。PTX和TXA联合组细胞线粒体膜电消失较单独用药组明显,两药合用具有协同作用(q=2.54)。结论:TSA和PTX有促进Ark2细胞凋亡的作用,去乙酰化酶抑制剂导致的非组蛋白乙酰化和线粒体膜电位的消失是其可能的抗肿瘤机制。 BACKGROUND & OBJECTIVE: Patients suffered from advanced endometrial cancer have poor prognosis. The five-year survival is only 25%. Histone deacetylase inhibitors have shown promise in the treatment for a variety of malignancies. In combination with traditional cytotoxic chemotherapy, histone deacetylase inhibitors can enhance the survival rate of cancer patients. This study was to investigate the effect and mechanism of trichostatin A (TSA), a histone deacetylase inhibitor, combined with paclitaxel (PTX) on the apoptosis of human endometrial carcinoma cell line Ark2. METHODS, Ark2 cells were cultured in RPMI-1640 and treated with PTX alone, TSA alone or the two drugs in combination. Cell apoptosis was detected using Annexin V and Hoechst staining; perturbation of mitochondrial membrane potential was detected using MitoTracker red Poly (ADP-ribose) polymerase; caspase-9 degradation products and tubulin acetylation were detected by Western blot. RESULTS, Results of Annexin V showed that PTX (1.5 nmol/L) plus TSA (25 nmol/L) induced a significantly higher apoptotic rate (45.2%) than PTX alone (14.1%) or TSA alone (11.2%) did in Ark2 cells after drug treatment for three days. The results of Hoechst staining and Annexin V were consistent. A loss of mitochondrial membrane potential could activate the apoptotic cascade. Cleavages of PARP and caspase-9 were significantly apparent in PTX plus TSA group than in PTX group or TSA group (P〈0.05). PTX and TSA could induce tubulin acetylation. PTX in combination with TSA increased acetylated tublins and microtubule stability compared with either drug alone. The loss of mitochondrial membrane potential was more dramatic in the drug combination group than the single drug group. The effects of TSA and PTX were synergistic (q=2.54). CONCLUSION, TSA and PTX could induce apoptosis of Ark2 cells, which may be through the loss of mitochondrial membrane potential and acetylation of non-histone proteins induced by histone deacetylase inhibitors.
出处 《癌症》 SCIE CAS CSCD 北大核心 2008年第8期816-821,共6页 Chinese Journal of Cancer
关键词 曲古抑菌素A 紫杉醇 Ark2细胞 凋亡 微管稳定性 线粒体膜电位 Trichostatin A Paclitaxel ArK2 cell Apoptosis Microtubule stabilization Mitochondrial membrane potential
  • 相关文献

参考文献13

  • 1Vogelauer M, Wu J, Suka N, et al. Global histone acetylation and deacetylation in yeast [J]. Nature, 2000,408 (6811 ) : 495-498.
  • 2Strahl B D, Allis C D. The language of covalent histone modifications [ J ]. Nature, 2000,403 ( 6765 ) : 41-45.
  • 3Villar-Garea A, Imhof A. The analysts of histone modifications [J]. Biochim Biophys Acta, 2006, 1764(12) : 1932-1939.
  • 4Dhordain P, Lin R J, Quief S, et al. The LAZ3 (BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression [J]. Nucleic Acids Res, 1998,26 (20) : 4645-4651.
  • 5Marks P, Rifkind R A, Richon V M, et al. Histone deacetylases and cancer: causes and therapies [J]. Nat Rev Cancer, 2001,1 (3) : 194-202.
  • 6Johnstone R W, Licht J D. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? [J]. Cancer Cell, 2003,4( 1 ) : 13-18.
  • 7Cheung W L, Briggs S D, Allis C D. Acetylation and chromosomal functions [J]. Curr Opin Cell Biol, 2000, 12 (3) : 326-333.
  • 8Struhl K. Histone acetylation and transcriptional regulatory mechanisms [J]. Genes Dev, 1998,12(5):599-606.
  • 9Zhang Y, Li N, Caron C, et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo [J]. EMBO J, 2003,22(5) : 1168-1179.
  • 10Schift P B, Horwitz S B. Taxol stabilizes microtubules in mouse fibroblast cells [J]. Proc Natl Acad Sci USA, 1980,77 (3) : 1561-1565.

二级参考文献15

  • 1刘建民,魏虎来,张哲文.维生素E琥珀酸酯诱导耐药白血病K562/ADM细胞凋亡的研究[J].肿瘤防治杂志,2005,12(5):325-328. 被引量:5
  • 2JAGASIAR, GROTE P, WESTERMANN B, et al. DRP-1-mediated mitochondrial fragmentation during EGL-1-inducedc ell death in C. elegans[J]. Nature, 2005, 433(7027): 754-760.
  • 3LI YC, FUNG KP, KWOK TT, etal. Mitochondria-targeting drug oligomycin blocked P glycoprotein activity and triggered apoptosis in doxorubicin-resistant HepG2 cells [J]. Chemotherapy, 2004, 50(2): 55-62.
  • 4WEBER T, DALEN H, ANERA L, etal. Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate,an agent with antineoplastic activity: comparison with receptor mediated pro apoptotic signaling[J]. Biochemistry, 2003,42(14):4277-4291.
  • 5WILKINSRC, KUTZNER BC, TRUONG M, etal. Analysis of radiation-induced apoptosis in human lymphocytes: flow cytometry using Annexin Ⅴ and propidium iodide versus the neutral comet assay[J]. Cytometry, 2002, 48(1): 14-19.
  • 6USHMOROV A, RATTER F, LEHMANN V, et al. Nitricoxide induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release[ J ].Blood, 1999, 93(7): 2342-2352.
  • 7ALLEVAR, BENASSIMS, TOMASETTIM, etal. Alphatocopheryl succinate induces cytostasis and apoptosis in osteosarcoma cells: the role of E2F1 [ J]. Biochem Biophys Res Commun, 2005, 331(4): 1515-1521.
  • 8ZHANG Y, WANG H, I.I J, et al. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12 lipoxygenase activation [J ]. J Neurosci, 2004, 24 (47):10616 -10627.
  • 9NOTARBARTOI.O M, CERVEI.I.O M, DUSONCHET L, et al. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P glycoprotein, Fas and of the novel anti-apoptosis factors IAP[J]. Cancer Lett, 2002, 180(1): 91-101.
  • 10WANG XF, WITTING PK, SALVATOREBA, et al. Vitarain E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway[J]. Biochem Biophys Res Commun, 2005, 326(2) : 282-289.

共引文献5

同被引文献29

  • 1JC Becker,C Müller-Tidow,H Serve,W Domschke,T Pohle.Role of receptor tyrosine kinases in gastric cancer: New targets for a selective therapy[J].World Journal of Gastroenterology,2006,12(21):3297-3305. 被引量:19
  • 2郝淑兰(综述),刘丽坤(审校),李宜放(审校).胃癌细胞多药耐药机制及耐药性逆转[J].肿瘤研究与临床,2007,19(1):68-70. 被引量:5
  • 3吴智群,张远强.TSA对人胃癌细胞SGC-7901基因表达的影响[J].现代肿瘤医学,2007,15(4):502-505. 被引量:2
  • 4陆颖影,靖大道,王兴鹏,吴恺.吲哚美辛与埃罗替尼对胰腺癌细胞生长的协同抑制作用[J].胃肠病学,2007,12(4):209-213. 被引量:3
  • 5Frikeche J, Peric Z, Brissot E, et al. Impact of HDAC in- hibitors on dendritic cell functions [ J ]. Exp Hematol, 2012, 40:783 -791.
  • 6Mai A, Perrone A, Nebbioso A, et al. Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: histone deacetylase inhibition and in-cell activities [ J ]. Bioorg Med Chem Lett, 2008, 18 : 2530 - 2535.
  • 7Lin Z, Bazzaro M, Wang MC, et al. Combination of pro- teasome and HDACs inhibitors for therapy of uterine cervi- cal cancer[ J]. Clin Cancer Res, 2009, 15:570 - 577.
  • 8Lee YS, Lim KH, Guo X, et al. The cytoplasmic deacety- lase HDAC6 is required for efficient oncogenic tumorigene- sis[ J]. Clin Cancer Res, 2008, 68:7561 -7569.
  • 9Zhang Z, Yamashita H, Toyama T, et al. HDAC6 expres- sion is correlated with better survival in breast cancer[ J ].Clin Cancer Res, 2004, 10 : 6962 - 6968.
  • 10Meng J, Zhang HH, Zhou CX, et al. The histone deacety- lase inhibitor trichostatin A induces cell cycle arrest and ap- optosis in colorectal cancer cells via p53-dependent and -in- dependent pathways [ J ]. Oncol Rep, 2012, 28:384 - 388.

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部